News | November 27, 2022
LPU organizes conference on welfare of global community
Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days
Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days
In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history
The conference is also expected to pave the way for nations to come out with bold and specific political commitments in the 2024 UN General Assembly High-Level Meeting on AMR
The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
The company is focussed on increasing the capacity utilizations while controlling costs
First and only next-generation protein-based adjuvanted COVID-19 booster approved in Europe
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
India will become a digital health leader, as we have the world’s best technical manpower required and our data is the cheapest in the world, approaching 100 percent coverage
Subscribe To Our Newsletter & Stay Updated
